• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PACS/IS vendors need to clear up confusion

Article

PACS/IS vendors need to clear up confusionIt was refreshing to see virtually all the major information systems vendors displaying PACS technology at February's Healthcare Information and Management Systems Society meeting in Orlando. One hopes

PACS/IS vendors need to clear up confusion

It was refreshing to see virtually all the major information systems vendors displaying PACS technology at February's Healthcare Information and Management Systems Society meeting in Orlando. One hopes this can be taken as a sign that radiology images can take their rightful place alongside other clinical data that have been the primary, if not exclusive, focus of IS companies for the past several years.

While the inclusion of radiology is a plus, few, if any, of the IS providers had any idea of either the implications or applications of PACS technology. They understand the big picture regarding the electronic patient record (EPR), but are lost in explaining how PACS works or can be integrated with their systems. The opposite extreme was displayed by PACS vendors, who understand PACS technology exceptionally well but have a limited knowledge of requirements for integrating PACS into an EPR.

Most hospital IS managers, who are tasked with implementing PACS, understand little of the requirements and issues surrounding the technology. They look to vendors for help. And what do they get? For the most part, corporate hype and acronym abuse. They recognize PACS is in their future, however, and need to believe that the approach they're taking makes sense. Achieving PACS market growth requires a warm and fuzzy feeling for the technology. If HIMSS is any indication, we're halfway there already. They've got the fuzzy feeling. All we need now is to provide these PACS decision-makers with the warm part.

-Michael J. Cannavo, president
Image Management Consultants

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.